Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, the Netherlands, Netherlands
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Discontinuation of Infliximab Treatment in IBD Patients: A Comparison Between Patients Who Retransitioned to Originator and Those Who Remained on Biosimilar
Saturday, August 27, 20221:45 PM - 1:50 PM CEST
